Best Practices for Implementing Dual Endothelin Angiotensin Receptor Antagonist Therapeutics in Patients with IgAN - AcademicCME

Best Practices for Implementing Dual Endothelin Angiotensin Receptor Antagonist Therapeutics in Patients with IgAN

0.50

Already have an Account? Log In
Don’t have an account? Register Today

Recent Courses

Unmet Needs in the Management of Atrial Fibrillation (AF)

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Pathophysiology, Diagnosis, and ...

FcRn Inhibition for the Treatment of Generalized Myasthenia Gravis (gMG): Patient Selectio...